Literature DB >> 1944558

Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

M C Chartier-Harlin1, F Crawford, H Houlden, A Warren, D Hughes, L Fidani, A Goate, M Rossor, P Roques, J Hardy.   

Abstract

A mutation at codon 717 of the beta-amyloid precursor protein gene has been found to cosegregate with familial Alzheimer's disease in a single family. This mutation has been reported in a further five out of approximately 100 families multiply affected by Alzheimer's disease. We have identified another family, F19, in which we have detected linkage between the beta-amyloid precursor protein gene and Alzheimer's disease. Direct sequencing of exon 17 in affected individuals from this family has revealed a base change producing a Val----Gly substitution, also at codon 717. The occurrence of a second allelic variant at codon 717 linked to the Alzheimer's phenotype supports the hypothesis that they are pathogenic mutations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1944558     DOI: 10.1038/353844a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  243 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

2.  Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif.

Authors:  Lisa-Marie Munter; Anne Botev; Luise Richter; Peter W Hildebrand; Veit Althoff; Christoph Weise; Daniela Kaden; Gerd Multhaup
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

3.  BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.

Authors:  M Farzan; C E Schnitzler; N Vasilieva; D Leung; H Choe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 4.  Mouse models of Alzheimer's disease.

Authors:  Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2011-11-28       Impact factor: 4.077

5.  Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease.

Authors:  R B Knowles; C Wyart; S V Buldyrev; L Cruz; B Urbanc; M E Hasselmo; H E Stanley; B T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 6.  Vaccines for Alzheimer's disease: how close are we?

Authors:  Christopher Janus
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Repression of the beta-amyloid gene in a Hox-3.1-producing cell line.

Authors:  S M Violette; C S Shashikant; J M Salbaum; H G Belting; J C Wang; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 8.  Role of Glutamate and NMDA Receptors in Alzheimer's Disease.

Authors:  Rui Wang; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Amyloid beta-protein activates tachykinin receptors and inositol trisphosphate accumulation by synergy with glutamate.

Authors:  H Kimura; D Schubert
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

10.  RFLP analysis for APP 717 mutations associated with Alzheimer's disease.

Authors:  S R Zeldenrust; J Murrell; M Farlow; B Ghetti; A D Roses; M D Benson
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.